Analyst Consensus ?
ConsensusHold39 ratings
Bullish1846.1%
Neutral2051.3%
Bearish12.6%
FN2 Earnings Intelligence
Xylem Inc. analyst ratings
Xylem Inc. (XYL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$88.23Current
$107Low
$145.96Average
$170High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| JP Morgan | Neutral | Neutral | Maintain | Oct 19, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 15, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 14, 2026 |
| Barclays | Overweight | Overweight | Maintain | Oct 13, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 12, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Jefferies | Buy | Buy | Maintain | Aug 24, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 29, 2026 |
| Baird | Outperform | Outperform | Maintain | Jul 29, 2026 |
| TD Cowen | Hold | Hold | Maintain | Dec 5, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Dec 12, 2024 |
| Argus Research | Buy | Buy | Maintain | May 29, 2024 |
| Deutsche Bank | Buy | Hold | Upgrade | Nov 21, 2023 |
| Melius Research | Buy | Hold | Upgrade | Oct 2, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 14, 2023 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jan 18, 2023 |
| Raymond James | Underperform | Market Perform | Downgrade | Jan 4, 2023 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 16, 2022 |
| Goldman Sachs | Neutral | Neutral | Maintain | Nov 3, 2022 |
| Credit Suisse | Neutral | Neutral | Maintain | Nov 2, 2022 |
| Rosenblatt | Hold | Buy | Downgrade | Oct 1, 2021 |
| Janney Montgomery Scott | Neutral | Neutral | Maintain | Jun 3, 2020 |
| Janney Capital | Neutral | Neutral | Maintain | Jun 3, 2020 |
| Canaccord Genuity | Hold | Hold | Maintain | Feb 7, 2020 |
| Seaport Global | Neutral | Buy | Downgrade | Nov 4, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | May 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Oct 31, 2018 |
| Vertical Research | Hold | Sell | Upgrade | Oct 18, 2018 |
| Boenning & Scattergood | Neutral | Outperform | Downgrade | Nov 28, 2016 |
| Wedbush | Neutral | Outperform | Downgrade | Apr 11, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 5, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 5, 2016 |
| DA Davidson | Neutral | Neutral | Maintain | Oct 29, 2014 |
| Keybanc | Hold | Buy | Downgrade | Oct 30, 2013 |
| Brean Capital | Buy | Hold | Upgrade | Oct 29, 2013 |
| BB&T Capital | Hold | Buy | Downgrade | Jul 30, 2013 |
| CL King | Neutral | Buy | Downgrade | Apr 15, 2013 |
| Ladenburg Thalmann | Neutral | Buy | Downgrade | Oct 18, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $88.23. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Stifel Nicolaus | Nathan Jones | $141 | $104.07 | +59.8% | Oct 19, 2026 |
| Barclays | William Grippin | $139 | $102.59 | +57.5% | Oct 13, 2026 |
| UBS | Analyst unavailable | $112 | $101.84 | +26.9% | Oct 5, 2026 |
| Jefferies | Analyst unavailable | $150 | $113.87 | +70.0% | Aug 24, 2026 |
| UBS | Analyst unavailable | $138 | $121.93 | +56.4% | Aug 13, 2026 |
| UBS | Joshua Spector | $135 | $116.48 | +53.0% | Jul 30, 2026 |
| Mizuho Securities | Analyst unavailable | $130 | $124.97 | +47.3% | Jul 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $160 | $124.97 | +81.3% | Jul 29, 2026 |
| Robert W. Baird | Michael Halloran | $165 | $124.97 | +87.0% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $159 | $124.97 | +80.2% | Jul 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $157 | $122.78 | +77.9% | Jul 20, 2026 |
| RBC Capital | Analyst unavailable | $159 | $124.53 | +80.2% | Jul 16, 2026 |
| Jefferies | Stephen Volkmann | $140 | $112.04 | +58.7% | Jun 25, 2026 |
| UBS | Analyst unavailable | $133 | $116.4 | +50.7% | Apr 29, 2026 |
| Oppenheimer | Bryan Blair | $158 | $116.4 | +79.1% | Apr 29, 2026 |
| Stifel Nicolaus | Analyst unavailable | $159 | $117.91 | +80.2% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $154 | $117.91 | +74.5% | Apr 29, 2026 |
| UBS | Analyst unavailable | $132 | $120.46 | +49.6% | Apr 21, 2026 |
| Stifel Nicolaus | Nathan Jones | $163 | $128.85 | +84.7% | Apr 14, 2026 |
| UBS | Joshua Spector | $152 | $129.4 | +72.3% | Apr 9, 2026 |
| UBS | Joshua Spector | $155 | $128.2 | +75.7% | Feb 13, 2026 |
| Oppenheimer | Analyst unavailable | $165 | $127.02 | +87.0% | Feb 12, 2026 |
| Goldman Sachs | Analyst unavailable | $158 | $126.77 | +79.1% | Feb 11, 2026 |
| Mizuho Securities | Analyst unavailable | $138 | $128.18 | +56.4% | Feb 11, 2026 |
| Stifel Nicolaus | Analyst unavailable | $175 | $128.92 | +98.3% | Feb 11, 2026 |
| Robert W. Baird | Analyst unavailable | $161 | $128.92 | +82.5% | Feb 11, 2026 |
| Barclays | William Grippin | $166 | $141.33 | +88.1% | Jan 7, 2026 |
| Mizuho Securities | Brett Linzey | $150 | $137.11 | +70.0% | Jan 5, 2026 |
| Stifel Nicolaus | Analyst unavailable | $178 | $153.42 | +101.7% | Oct 29, 2025 |
| Argus Research | Analyst unavailable | $170 | $153.4 | +92.7% | Oct 29, 2025 |
| Mizuho Securities | Brett Linzey | $160 | $150.5 | +81.3% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $176 | $153.48 | +99.5% | Oct 29, 2025 |
| Robert W. Baird | Michael Halloran | $178 | $153.48 | +101.7% | Oct 29, 2025 |
| Barclays | William Grippin | $172 | $150.5 | +94.9% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $165 | $142.18 | +87.0% | Sep 18, 2025 |
| UBS | Analyst unavailable | $168 | $143.61 | +90.4% | Aug 5, 2025 |
| UBS | Damian Karas | $165 | $127.5 | +87.0% | Aug 13, 2024 |
| Robert W. Baird | Michael Halloran | $170 | $133.48 | +92.7% | Jul 31, 2024 |
| Oppenheimer | Bryan Blair | $152 | $139.4 | +72.3% | May 31, 2024 |
| Argus Research | John Eade | $165 | $140.36 | +87.0% | May 29, 2024 |
| Mizuho Securities | Brett Linzey | $135 | $135.99 | +53.0% | May 3, 2024 |
| RBC Capital | Deane Dray | $162 | $135.99 | +83.6% | May 3, 2024 |
| Robert W. Baird | Michael Halloran | $155 | $135.99 | +75.7% | May 3, 2024 |
| Wolfe Research | Brad Hewitt | $143 | $128.27 | +62.1% | Apr 8, 2024 |
| RBC Capital | Deane Dray | $153 | $127.25 | +73.4% | Apr 4, 2024 |
| Stifel Nicolaus | Nathan Jones | $133 | $99.8 | +50.7% | Aug 18, 2023 |
| Citigroup | Analyst unavailable | $121 | $106.85 | +37.1% | Feb 8, 2023 |
| Citigroup | Analyst unavailable | $123 | $111.23 | +39.4% | Dec 9, 2022 |
| Atlantic Equities | Richard Radbourne | $129 | $112.13 | +46.2% | Nov 16, 2022 |
| Loop Capital Markets | Scott Graham | $120 | $127.19 | +36.0% | Nov 22, 2021 |
| Argus Research | John Eade | $150 | $129.82 | +70.0% | Nov 12, 2021 |
| Citigroup | Andrew Kaplowitz | $131 | $125.7 | +48.5% | Aug 4, 2021 |
| Goldman Sachs | Brian K. Lee | $107 | $116.2 | +21.3% | May 5, 2021 |
Track every rating change on XYL the moment it posts. Free to start.
Start freeGet the XYL recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.